Grifols, S.A. (NASDAQ: GRFS - Get Free Report) has been given a consensus recommendation of "Hold" by the five ratings firms that are currently covering the company, MarketBeat Ratings reports. One eq
Grifols, S.A. (NASDAQ: GRFS - Get Free Report) shares crossed above its two hundred day moving average during trading on Wednesday. The stock has a two hundred day moving average of $9.49 and traded a
Shares of Grifols, S.A. (NASDAQ: GRFS - Get Free Report) have received a consensus rating of "Hold" from the five analysts that are currently covering the company, MarketBeat.com reports. One investme
Grifols, S.A. has executed a turnaround, with Q3 '25 results confirming improved fundamentals, reduced leverage, and restored dividend, supporting a renewed 'Buy' rating. GRFS now trades at a normaliz
Grifols (NASDAQ: GRFS - Get Free Report) and ProPhase Labs (NASDAQ: PRPH - Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on th
Exploring the Strategic Moves of Brandes Investment Partners, LP (Trades, Portfolio) in Q3 2025 Brandes Investment Partners, LP (Trades, Portfolio) recently su
Grifols (GRFS) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates c
Grifols, S.A. (OTCPK:GIKLY) Q3 2025 Earnings Call November 4, 2025 12:30 PM EST Company Participants Daniel Segarra - Head of Investor Relations & Sustainability and Vice President Jose Ignacio Abia B

Top Biotech Stocks Riding The Rally

03:15pm, Tuesday, 04'th Nov 2025
Biotech stocks have rebounded after years of underperformance but remain well below their 2021 highs. Successful drug launches, strong trial results, and falling interest rates have boosted stock pric
Here is how Grifols (GRFS) and Arcutis Biotherapeutics, Inc. (ARQT) have performed compared to their sector so far this year.
The current market is all about momentum, but investors don't need to buy overpriced high-growth stocks to participate in gains. If you dig deep enough, you can find undervalued stocks with growth pot
Investors looking for stocks in the Medical - Drugs sector might want to consider either Grifols (GRFS) or Zoetis (ZTS). But which of these two stocks offers value investors a better bang for their bu
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Investors looking for stocks in the Medical - Drugs sector might want to consider either Grifols (GRFS) or Stevanato Group (STVN). But which of these two stocks offers value investors a better bang fo

Is Grifols (GRFS) Stock Undervalued Right Now?

10:40am, Friday, 10'th Oct 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE